These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 28455295
1. Impact of stroke volume on cardiovascular risk during progression of aortic valve stenosis. Lønnebakken MT, De Simone G, Saeed S, Boman K, Rossebø AB, Bahlmann E, Gohlke-Bärwolf C, Gerdts E. Heart; 2017 Sep; 103(18):1443-1448. PubMed ID: 28455295 [Abstract] [Full Text] [Related]
3. Sex differences in cardiovascular outcome during progression of aortic valve stenosis. Cramariuc D, Rogge BP, Lønnebakken MT, Boman K, Bahlmann E, Gohlke-Bärwolf C, Chambers JB, Pedersen TR, Gerdts E. Heart; 2015 Feb; 101(3):209-14. PubMed ID: 25301859 [Abstract] [Full Text] [Related]
4. Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis. Gerdts E, Rossebø AB, Pedersen TR, Cioffi G, Lønnebakken MT, Cramariuc D, Rogge BP, Devereux RB. Circ Cardiovasc Imaging; 2015 Nov; 8(11):e003644; discussion e003644. PubMed ID: 26489804 [Abstract] [Full Text] [Related]
5. Global left ventricular load in asymptomatic aortic stenosis: covariates and prognostic implication (the SEAS trial). Rieck AE, Gerdts E, Lønnebakken MT, Bahlmann E, Cioffi G, Gohlke-Bärwolf C, Ray S, Cramariuc D. Cardiovasc Ultrasound; 2012 Nov 05; 10():43. PubMed ID: 23126645 [Abstract] [Full Text] [Related]
6. Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction. Jander N, Minners J, Holme I, Gerdts E, Boman K, Brudi P, Chambers JB, Egstrup K, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Rossebø A, Pedersen TR, Skjærpe T, Willenheimer R, Wachtell K, Neumann FJ, Gohlke-Bärwolf C. Circulation; 2011 Mar 01; 123(8):887-95. PubMed ID: 21321152 [Abstract] [Full Text] [Related]
7. Impact of flow and left ventricular strain on outcome of patients with preserved left ventricular ejection fraction and low gradient severe aortic stenosis undergoing aortic valve replacement. Kamperidis V, van Rosendael PJ, Ng AC, Katsanos S, van der Kley F, Debonnaire P, Joyce E, Sianos G, Marsan NA, Bax JJ, Delgado V. Am J Cardiol; 2014 Dec 15; 114(12):1875-81. PubMed ID: 25438916 [Abstract] [Full Text] [Related]
10. Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study. Bang CN, Dalsgaard M, Greve AM, Køber L, Gohlke-Baerwolf C, Ray S, Rossebø AB, Egstrup K, Wachtell K. Int J Cardiol; 2013 Oct 03; 168(3):2322-7. PubMed ID: 23416018 [Abstract] [Full Text] [Related]
11. Impact of estimated left atrial volume on prognosis in patients with asymptomatic mild to moderate aortic valve stenosis. Losi MA, Mancusi C, Midtbø H, Saeed S, de Simone G, Gerdts E. Int J Cardiol; 2019 Dec 15; 297():121-125. PubMed ID: 31604654 [Abstract] [Full Text] [Related]
14. Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF. Jander N, Hochholzer W, Kaufmann BA, Bahlmann E, Gerdts E, Boman K, Chambers JB, Nienaber CA, Ray S, Rossebo A, Pedersen TR, Wachtell K, Gohlke-Bärwolf C, Neumann FJ, Minners J. Heart; 2014 Dec 15; 100(24):1946-53. PubMed ID: 25217488 [Abstract] [Full Text] [Related]
17. Impact of low flow on the outcome of high-risk patients undergoing transcatheter aortic valve replacement. Le Ven F, Freeman M, Webb J, Clavel MA, Wheeler M, Dumont É, Thompson C, De Larochellière R, Moss R, Doyle D, Ribeiro HB, Urena M, Nombela-Franco L, Rodés-Cabau J, Pibarot P. J Am Coll Cardiol; 2013 Aug 27; 62(9):782-8. PubMed ID: 23770162 [Abstract] [Full Text] [Related]
18. Echocardiographic aortic valve calcification and outcomes in women and men with aortic stenosis. Thomassen HK, Cioffi G, Gerdts E, Einarsen E, Midtbø HB, Mancusi C, Cramariuc D. Heart; 2017 Oct 27; 103(20):1619-1624. PubMed ID: 28698175 [Abstract] [Full Text] [Related]
19. Effect Modifications of Lipid-Lowering Therapy on Progression of Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis [SEAS] Study). Greve AM, Bang CN, Boman K, Egstrup K, Forman JL, Kesäniemi YA, Ray S, Pedersen TR, Best P, Rajamannan NM, Wachtell K. Am J Cardiol; 2018 Mar 15; 121(6):739-745. PubMed ID: 29361285 [Abstract] [Full Text] [Related]
20. Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study. Greve AM, Bang CN, Berg RM, Egstrup K, Rossebø AB, Boman K, Nienaber CA, Ray S, Gohlke-Baerwolf C, Nielsen OW, Okin PM, Devereux RB, Køber L, Wachtell K. Int J Cardiol; 2015 Feb 01; 180():122-8. PubMed ID: 25438232 [Abstract] [Full Text] [Related] Page: [Next] [New Search]